Cellectar Biosciences Announces Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Cellectar Biosciences (CLRB) Reports Q3 Loss of $0.25
November 12, 2015 5:13 PM ESTCellectar Biosciences (NASDAQ: CLRB) reported Q3 EPS of ($0.25), versus $0.06 reported last year.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
... More